We are excited to announce that Hemanth J. Varghese has been appointed as Chief Strategy Officer at Viatris. Hemanth brings over 20 years of strategy, operations and corporate development experience in the healthcare space in multi-national companies. We are confident that Hemanth will play a pivotal role in shaping the future of Viatris, and we look forward to seeing the successes that will follow!
Read more about Hemanth’s appointment here: https://lnkd.in/g6hhJgBA
Congratulations to Paul Wilson and Cagent Vascular. It has been a privilege working with you both!
Read more about Paul’s appointment here: https://lnkd.in/g3qQ4SQ3
Kicking 2025 off with a bang! We’re thrilled to announce we’ve successfully placed several Senior-Level Portfolio Executives in the Global Generic Pharmaceutical space. A huge thank you to our incredible clients for trusting us to strengthen their Commercial Portfolio teams.
At Strawn Arnold, we take pride in sharing our industry expertise and are committed to building strong, long-term relationships.
We are happy to announce the placement of André Soresini at Apotex as Vice President, LATAM and Country President, Mexico. André’s exceptional leadership and vision have had a profound impact on the lives of patients across Latin America, inspiring everyone around him.
A big thanks to Apotex for trusting us with your talent needs. We are confident that André will be a valuable asset to your team and contribute significantly to your continued success.
Congratulations, André! Here’s to new beginnings and a bright future ahead!
We are excited to share the announcement that Alan Bash has been appointed as the new President of CARVYKTI at Legend Biotech. His extensive experience in oncology and leadership roles at prominent biotech companies, including his recent tenure as CEO at ZielBio, positions him perfectly to enhance Legend’s impact in the treatment of Multiple Myeloma. https://lnkd.in/eCKW6t3S
Congratulations to Alan and the entire Legend Biotech team from Strawn Arnold! We look forward to seeing the growth that will emerge under Alan’s leadership.
We are delighted to share the announcement that Greg Hamilton has been appointed as the new Chief Executive Officer of Accellix, Inc. Greg’s extensive background in molecular diagnostics and life science tools coupled with years of strategic leadership experience makes him the perfect fit to lead Accellix into its next phase of growth.
With over 25 years of experience, Greg has a proven track record of driving innovation and success. His leadership will be pivotal as Accellix continues to expand its impact in the cell therapy and blood bank markets.
Join us in congratulating Greg on this new role! We are eager to see the achievements that lie ahead for Accellix under his guidance.
We are thrilled to congratulate Anthony Zolfo on his recent appointment as Associate General Counsel at Apotex Inc. Tony brings a wealth of experience from his impressive career in pharma and healthcare, including key positions at Zelis Healthcare and Sandoz. We are confident that Tony and Apotex will achieve great success together in fulfilling the Apotex mission to improve access to affordable and innovative medicines for patients worldwide. Congratulations!
Congratulations to Nick Seibert on joining Future Pak LLC as Vice President of Business Development. We are thrilled to have partnered with Future Pak on this exceptional placement. Nick brings superb talent at building strong relationships coupled with his sales and business development acumen in pharmaceutical packaging to his new role. We wish him and Future Pak well in this great match.
Congratulations to J’Aime Conrod on her new role as VP, Government Business & Healthcare Policy. We are delighted to have partnered with Amneal Pharmaceuticals on her placement. J’Aime brings a wealth of experience and expertise with her, and we look forward to seeing all the great things she will do in the years to come.
